This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Investigators from Denver Health and Hospital Authority and the University of Colorado School of Medicine, Aurora, CO, compared medication completion rates in children with latent tuberculosis (TB) infection (LTBI) treated with either a 9-month regimen of isoniazid (9H) or a 4-month regimen of rifampin (4R). Study participants were patients <18 years old with a diagnosis of LTBI at the Denver Metro Tuberculosis Clinic (DMTBC) between 2006 and 2015. The investigators reviewed medical records of study children and abstracted data on demographic characteristics (including age, primary language, and birth country); clinical characteristics; and whether the patient completed the treatment regimen and, if not completed, the reasons for not …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.